WASHINGTON, D.C. – Four former heads of the U.S. Environmental Protection Agency will be testifying before Congress next week as a part of a key House oversight panel’s investigation into the Trump administration’s management of the agency.
WASHINGTON, D.C. – U.S. Reps. Diana DeGette (D-CO) and Barbara Lee (D-CA), co-chairs of the Congressional Pro-Choice Caucus, issued the following statement today in response to the Trump administration’s new proposed rule that would allow health insurers and providers to discriminate against patients who have previously had an abortion:
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO), co-chair of the Congressional Pro-Choice Caucus, joined with several of her Congressional colleagues today to introduce legislation to prohibit states from enacting laws that restrict access to abortion care.
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO) announced today that she believes it’s time for Congress to officially launch an impeachment inquiry against President Donald Trump.
WASHINGTON, D.C. – The U.S. Environmental Protection Agency is refusing to send a witness Tuesday to testify before a key House oversight panel that’s investigating the agency’s efforts to undo one of the Obama administration’s most successful anti-pollution rules.
WASHINGTON, D.C. – The U.S. House of Representatives, by a vote of 236 – 173, passed landmark legislation today to end discrimination against LGBTQ Americans.
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO) introduced legislation today to make physical therapy more accessible for individuals living in rural or underserved areas of the country.
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO) introduced legislation today to curb the large amounts of methane pollution and waste that are being released into the atmosphere each year by oil and gas producers across the country.
WASHINGTON, D.C. – U.S. Reps. Diana DeGette (D-CO) and Tom Reed (R-NY), the co-chairs of the Congressional Diabetes Caucus, introduced bipartisan legislation today to continue funding a key federal diabetes research program for an additional five years, and increase its annual funding from $150 million to $200 million a year.
WASHINGTON, D.C. – It’s hard to get 378 members of Congress to agree on almost anything these days, but continuing to fund a special diabetes research program that’s working to find a cure to the disease seems to be one of the few things that nearly every member of the U.S. House is willing to support.